Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64,240 ILa | +0.58% |
|
+4.66% | -11.39% |
14/06 | Morgan Stanley Adjusts Price Target on NICE to $240 From $290, Maintains Overweight Rating | MT |
12/06 | RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.39% | 1.07TCr | |
+22.53% | 3,41400Cr | |
+17.88% | 9.34TCr | |
+15.82% | 8.68TCr | |
+50.55% | 5.75TCr | |
-20.29% | 4.87TCr | |
+38.23% | 4.81TCr | |
-23.39% | 4.74TCr | |
+76.52% | 4.04TCr | |
-4.63% | 2.71TCr |
- Stock Market
- Equities
- NICE Stock
- News NICE Ltd.
- Transcript : NICE Ltd., Q2 2022 Earnings Call, Aug 18, 2022